- Home
- COOK vs CNTB Comparison
COOK vs CNTB Comparison
Compare COOK & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COOK | CNTB |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.1M | 128.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | COOK | CNTB |
|---|---|---|
| Price | $1.03 | $2.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $2.04 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 910.5K | 298.5K |
| Earning Date | 11-05-2025 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $582,799,000.00 | $762,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $38,289.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.71 | $0.51 |
| 52 Week High | $2.70 | $3.28 |
Technical Indicators
Market Signals| Indicator | COOK | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 55.20 |
| Support Level | $1.00 | $2.11 |
| Resistance Level | $1.16 | $2.65 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 68.15 | 75.81 |
Price Performance
Historical ComparisonAbout COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.